Showing 1 - 20 results of 25 for search 'Keith A.A. Fox', query time: 0.07s
Refine Results
-
1
What’s new for ESC Congress 2013? (Amsterdam 30th August–4th September 2013) by Keith A.A. Fox
Published 2013-06-01
Article -
2
What's new for ESC Congress 2013? (Amsterdam 30th August–4th September 2013) by Keith A.A. Fox
Published 2013-06-01
Article -
3
-
4
-
5
The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The “Xarelto plus Acetylsalicylic Acid: Treatment Patterns and Outcomes in Patients with Atherosclerosis”... by Alexander Breitenstein, Alain Gay, Kai Vogtländer, Keith A. A. Fox, Jan Steffel
Published 2024-03-01
Article -
6
-
7
-
8
Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. by Marlous Hall, Tatendashe B Dondo, Andrew T Yan, Mamas A Mamas, Adam D Timmis, John E Deanfield, Tomas Jernberg, Harry Hemingway, Keith A A Fox, Chris P Gale
Published 2018-03-01
Article -
9
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER) by Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Published 2019-04-01
Article -
10
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome by Liping Zhang, Xiaoyu Yan, Partha Nandy, Stefan Willmann, Keith A. A. Fox, Scott D. Berkowitz, Amarnath Sharma, Anne Hermanowski-Vosatka, Stephan Schmidt, Jeffrey I. Weitz, Dirk Garmann, Gary Peters
Published 2019-07-01
Article -
11
Country and health expenditure are major predictors of withholding anticoagulation in atrial fibrillation patients at high risk of stroke by Bernard J Gersh, Deborah M Siegal, Karen Pieper, Anne-Céline Martin, Keith A A Fox, Saverio Virdone, Shinya Goto, Alexander G G Turpie, Frederik H Verbrugge, John Camm, Pantep Angchaisuksiri
Published 2023-11-01
Article -
12
Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention by Matthias Bossard, Christopher B. Granger, Jean‐Francois Tanguay, Gilles Montalescot, David P. Faxon, Sanjit S. Jolly, Petr Widimsky, Kari Niemela, Philippe Gabriel Steg, Madhu K. Natarajan, Peggy Gao, Keith A. A. Fox, Salim Yusuf, Shamir R. Mehta
Published 2017-11-01
Article -
13
Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction by Atul Anand, Sarah Cudmore, Shirley Robertson, Jacqueline Stephen, Kristin Haga, Christopher J. Weir, Scott A. Murray, Kirsty Boyd, Julian Gunn, Javaid Iqbal, Alasdair MacLullich, Susan D. Shenkin, Keith A. A. Fox, Nicholas Mills, Martin A. Denvir
Published 2020-03-01
Article -
14
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry by Ajay K Kakkar, Keith A A Fox, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Karen S Pieper, Alexander G G Turpie, Gloria Kayani, Seil Oh, Jörn Nielsen, Frank Cools, John Camm, Marianne Brodmann, Patricia Apenteng, Antonio C P Barretto
Published 2023-02-01
Article -
15
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial by Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Published 2021-10-01
Article -
16
Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial by George C. Leef, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Werner Hacke, Christopher C. Nessel, Daniel E. Singer, Keith A.A. Fox, Kenneth W. Mahaffey, Jonathan P. Piccini
Published 2017-11-01
Article -
17
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial by Gene R. Quinn, Anne S. Hellkamp, Graeme J. Hankey, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Maurizio Fava, Keith A. A. Fox, Jonathan L. Halperin, Kenneth W. Mahaffey, Christopher C. Nessel, Manesh R. Patel, Jonathan P. Piccini, Daniel E. Singer
Published 2018-08-01
Article -
18
Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF by Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A. A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey
Published 2019-08-01
Article -
19
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF by Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A. A. Fox, Robert M. Califf
Published 2016-03-01
Article -
20
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF re... by Jonathan P Piccini, A John Camm, Ajay K Kakkar, Keith A A Fox, Yukihiro Koretsune, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Samuel Z Goldhaber, Shinya Goto, Frank Misselwitz, Alexander G G Turpie, Freek W A Verheugt, Gloria Kayani, Seil Oh, Jitendra Pal Singh Sawhney, Janina Stepinska, Alex Parkhomenko
Published 2022-01-01
Article